Antagonistic effect of N-methyltyramine on alpha2-adrenoceptor in mice

Jpn J Pharmacol. 1999 Nov;81(3):313-5. doi: 10.1254/jjp.81.313.

Abstract

We examined the effect of N-methyltyramine (NMT) on alpha2-adrenoceptor. NMT (10(-8)-10(-3) M) inhibited the binding of [3H]p-aminoclonidine to alpha2-adrenoceptor dose-dependently. However, the IC50 value for NMT (5.53 x 10(-6) M) was higher than that for RX821002, an alpha2-adrenoceptor antagonist (1.07 x 10(-8) M). RX821002 (5 mg/kg, i.p.) inhibited hypermotility induced by scopolamine (8 mg/kg, s.c.) in male ddY mice. NMT (20 or 100 mg/kg, i.p.) was found to have a dose-dependent inhibitory effect similar to that of RX821002. These findings indicate that NMT has the properties of an alpha2-adrenoceptor antagonist. However, the affinity of NMT for alpha2-adrenoceptor is weaker than that of RX821002.

MeSH terms

  • Adrenergic alpha-2 Receptor Antagonists*
  • Adrenergic alpha-Agonists / metabolism
  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic alpha-Antagonists / metabolism
  • Adrenergic alpha-Antagonists / pharmacology*
  • Animals
  • Clonidine / analogs & derivatives
  • Clonidine / metabolism
  • Clonidine / pharmacology
  • Idazoxan / analogs & derivatives
  • Idazoxan / metabolism
  • Idazoxan / pharmacology
  • Male
  • Mice
  • Radioligand Assay
  • Receptors, Adrenergic, alpha-2 / metabolism
  • Scopolamine / antagonists & inhibitors
  • Scopolamine / pharmacology
  • Tyramine / analogs & derivatives*
  • Tyramine / metabolism
  • Tyramine / pharmacology

Substances

  • Adrenergic alpha-2 Receptor Antagonists
  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Receptors, Adrenergic, alpha-2
  • apraclonidine
  • Scopolamine
  • 2-methoxyidazoxan
  • methyl-4-tyramine
  • Clonidine
  • Tyramine
  • Idazoxan